Guerbet LLC, the U.S. subsidiary, was established in January of 2002.
Currently, Guerbet LLC is responsible for the marketing, sales, and distribution of the first macrocyclic and ionic gadolinium-based contrast in the USA, Dotarem® (gadoterate meglumine) Injection, the only oil-based based contrast agent currently available in the USA, Lipiodol® (ethiodized oil) Injection.
Guerbet LLC headquarters is located in Bloomington, IN with a second location in Princeton, NJ.
Dotarem® Full Prescribing Information Read more
Lipiodol® Full Prescribing Information Read more